Petros Pharmaceuticals, Inc. (PTPI) Total liabilities 2020–2024
Petros Pharmaceuticals, Inc. (PTPI) total liabilities at each fiscal year-end, per SEC filings.
$18.1MFY2024 · since FY2020: $52.4M → $18.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $18.1M | -15.1% |
| FY2023 | $21.3M | +35.6% |
| FY2022 | $15.7M | -50.6% |
| FY2021 | $31.8M | -39.2% |
| FY2020 | $52.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice